title: Inhibitory effect of cryptoporic acid E, a product from fungus Cryptoporus volvatus, on colon carcinogenesis induced with N-methyl-N-nitrosourea in rats and with 1,2-dimethylhydrazine in mice.
abstract: The antitumorigenic effect of cryptoporic acid E (CPA-E), a dimeric drimane sesquiterpenoid isolated from the fungus Cryptoporus volvatus, on colon carcinogenesis was investigated. Female F344 rats given an intrarectal instillation of 2 mg of N-methyl-N-nitrosourea 3 times weekly in weeks 1 and 2 were fed diet containing 0.2% CPA-E from week 3. Female ICR mice given 15 weekly intraperitoneal injections of 10 mg of 1,2-dimethylhydrazine/kg body weight during weeks 1 to 15 were fed diet containing 0.06% CPA-E from week 1. The experiment was terminated at week 35 for rats and at week 25 for mice. The incidence and the number of tumors per animal were reduced in CPA-E-fed animals compared to the controls: 31% vs. 75% (P less than 0.05) and 0.4 +/- 0.2 (SEM) vs. 0.9 +/- 0.2 (0.1 greater than P greater than 0.05) in rats, and 31% vs. 63% (0.1 greater than P greater than 0.05) and 0.4 +/- 0.2 vs. 2.4 +/- 0.8 (P less than 0.05) in mice (16 animals in each group). Intrarectal deoxycholic acid-induced colonic mucosal ornithine decarboxylase activity was significantly lowered in CPA-E-fed animals compared to controls. This shows an antipromoting activity of CPA-E against colon carcinogenesis. Thus, it was concluded that CPA-E inhibits colon cancer development in both rats and mice treated with 2 different colon carcinogens.
authors.affiliation: Akita University College of Allied Medical Science.
authors.forename: T
authors.initials: T
authors.lastname: Narisawa
authors.forename: Y
authors.initials: Y
authors.lastname: Fukaura
authors.forename: H
authors.initials: H
authors.lastname: Kotanagi
authors.forename: Y
authors.initials: Y
authors.lastname: Asakawa
mesh_terms: D019813:1,2-Dimethylhydrazine; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002273:Carcinogens / Q000633:toxicity*; D003106:Colon / Q000187:drug effects / Q000473:pathology; D003110:Colonic Neoplasms / Q000139:chemically induced* / Q000517:prevention & control*; D003840:Deoxycholic Acid / Q000494:pharmacology; D004127:Dimethylhydrazines / Q000633:toxicity*; D004790:Enzyme Induction; D005247:Feeding Behavior / Q000187:drug effects; D005260:Female; D007413:Intestinal Mucosa / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D008770:Methylnitrosourea / Q000633:toxicity*; D051379:Mice; D008813:Mice, Inbred ICR; D009955:Ornithine Decarboxylase / Q000032:analysis / Q000096:biosynthesis*; D011124:Polyporaceae; D051381:Rats; D011916:Rats, Inbred F344; D012717:Sesquiterpenes / Q000494:pharmacology*; D015430:Weight Gain / Q000187:drug effects
chemical_list: D016588:Anticarcinogenic Agents; D014408:Biomarkers, Tumor; D002273:Carcinogens; D004127:Dimethylhydrazines; D012717:Sesquiterpenes; D003840:Deoxycholic Acid; C069197:cryptoporic acid E; D008770:Methylnitrosourea; D009955:Ornithine Decarboxylase; D019813:1,2-Dimethylhydrazine